Skip to main content

Advertisement

Log in

ASO Visual Abstract: Preoperative Denosumab Therapy against Giant Cell Tumor of Bone Is Associated with an Increased Risk of Local Recurrence after Curettage Surgery

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Naofumi Asano MD, PhD.

Ethics declarations

Disclosure

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Asano, N., Saito, M., Kobayashi, E. et al. ASO Visual Abstract: Preoperative Denosumab Therapy against Giant Cell Tumor of Bone Is Associated with an Increased Risk of Local Recurrence after Curettage Surgery. Ann Surg Oncol 29, 4002–4003 (2022). https://doi.org/10.1245/s10434-022-11606-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-11606-0

Navigation